Vical and Brickell Announce Merger Agreement Business, Cutaneous T-cell lymphoma, Dermatology, Mergers, Pharmaceutical, Primary Axillary Hyperhidrosis, Psoriasis, Skin Diseases Vical Incorporated and Brickell Biotech Inc. announced a definitive merger agreement under which Brickell would merge with a wholly owned subsidiary of Vical in an all-stock transaction. Read more June 3, 2019/by GlobeNewswire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 GlobeNewswire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png GlobeNewswire2019-06-03 03:00:292019-06-03 12:58:12Vical and Brickell Announce Merger Agreement
